Skip to main content
Equibles

SLGL · Sol-Gel Technologies Ltd.

Track SLGL — free

Use SLGL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SLGL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$65.81 +0.83 (+1.28%) At close · Oct 20
Rebalance outlook locked
Market Cap
$212.74M
Shares
3.27M
Volume · Oct 20 44.89K Avg daily vol (3M) 53.88K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$65.81 Open$63.68 Day$63.68–66.98 52W close$30.64–97.97 Avg vol 30d44K Short int146K · 4.5% float · 3.0d Short vol36% DataJan 2020–Oct 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.79M
Trailing 12 months
Net income (TTM)
−$16.34M
Trailing 12 months
Revenue growth YoY
-96.6%
Year over year
Operating margin
-987.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-4.1%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+17.4%
Year over year · more shares
Price change (1Y)
+60.0%
Trailing year
Short interest
4.5%
Latest settlement · 3.0 days to cover
View all 122 metrics

Quarterly results

Revenue Net income Net loss
▲15804.1% $7.79M −$4.93M '19 Q2 ▼85.5% $1.13M −$7.07M '20 Q2 ▼18.1% $928,000 −$8.03M '21 Q2 ▲279.1% $3.52M −$134,000 '22 Q2 ▼83.1% $594,000 −$5.97M '23 Q2 ▲814.6% $5.43M $1.98M '24 Q2 ▲217.7% $17.26M $11.61M '25 Q2 LATEST ▼96.6% $591,000 −$3.68M '26 Q2

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Sell Momentum Neutral Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 17.3 · elevated Equity put/call 0.56
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −11%
below
Price vs 50-day avg −7%
below
RSI (14) 44
neutral
MACD trend Negative
52-week position 52%
mid-range
Momentum
relative strength
Neutral
1-month return +8%
trailing
6-month return −8%
trailing
YTD return +56%
this year
Relative strength −16%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $71 › 200d $74 — 200d above 50d
Institutional flow Accumulating
+14% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
4.45% of float · ▲ +19.3% MoM · 3.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
24 holders — near 3-yr high, broad support
Squeeze score 59
elevated · 0–100
Fundamentals
Excellent
Revenue growth +68%
Y/Y
EPS growth +42%
Y/Y
Free cash flow $275.0K
Quant / Vol
risk profile
Very High
Volatility 84%
annualized · 1-yr
Max drawdown −39%
past year
ATR 6.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−11% Bearish
Price vs 50-day avg
−7% Bearish
RSI (14)
44 Neutral
MACD trend
Negative Bearish
52-week position
52% Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $71 › 200d $74 — 200d above 50d
Institutional flow Accumulating
+14% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
4.45% of float · ▲ +19.3% MoM · 3.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
24 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $31 Now $66 · 52% Range high $98
vs 200-day avg -11% vs 50-day avg -7%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
SLGL
Sol-Gel Technologies Ltd.
this stock
$212.74M +56.2% +68.0% — 4.5%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $130.07B +13.5% +46.2% 29.9 1.8%
MRNA
Moderna, Inc.
 $90.58B +720.9% +4.3% — 7.7%
REGN
Regeneron Pharmaceuticals, Inc.
 $80.51B +4.6% +20.8% 19.4 2.1%
CSLLY
Csl Ltd
 $66.34B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
24
% held
40.4%
Net QoQ
+62.1K sh
Top holder
Opaleye Management Inc.
Held Float
View
Short & Settlement
Short Interest Rising
Shares short
145.8K
Days to cover
3.0d
Change
+23.6K sh
View
Short Volume
Short vol %
36%
As of
Oct 20, 2026
Short Total
View
Fails to Deliver
FTD shares
2.0K
Value
$143.7K
As of
Sep 30, 2026
View
Off-Exchange
Off-exchange %
20.5%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$19.4M
Net income (FY)
$-6.1M
EPS diluted
$-2.19
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 6, 2026
This year
7
View
Proposed Sales
Value
$12.6K
Shares
142
Filed
Mar 12, 2026
View
Earnings & Events
Investor Relations
Latest news
Sol-Gel Technologies to Host KOL…
Published
Sep 30, 2026
View

Performance

5D 20D 120D MTD YTD
SLGL -3.7% +8.0% -7.8% -11.4% +56.2%
SPY -1.2% -0.6% +8.1% +0.8% +12.8%
vs SPY -2.5% +8.5% -15.9% -12.2% +43.4%
Key facts CIK 1684693 CUSIP M8694L137 Visit website Investor relations